View ValuationPorvair 将来の成長Future 基準チェック /16Porvairは、3.7%と6.1%でそれぞれ年率3.7%で利益と収益が成長すると予測される一方、EPSはgrowで3.3%年率。主要情報3.7%収益成長率3.31%EPS成長率Machinery 収益成長16.7%収益成長率6.1%将来の株主資本利益率n/aアナリストカバレッジLow最終更新日21 May 2026今後の成長に関する最新情報お知らせ • Dec 16Porvair plc Provides Earnings Guidance for the Year Ended 30 November 2025Porvair plc provided earnings guidance for the year ended 30 November 2025. For the period, the Group expects revenue growth to be around 1% (2% at constant currency), with both operating profit and margin ahead of the prior year.すべての更新を表示Recent updatesお知らせ • Jun 12Porvair plc to Report Fiscal Year 2026 Results on Feb 08, 2027Porvair plc announced that they will report fiscal year 2026 results on Feb 08, 2027お知らせ • May 20Richard Bernstein Calls for Sale of PorvairOn May 19, 2026, Richard Bernstein, founder and former investment manager of Crystal Amber, announced that he is reportedly calling for a sale of Porvair plc. Richard Bernstein stated that he has written to the Company’s chairman John Nicholas urging him to explore strategic alternatives for the Company. Richard Bernstein said that the Company was an attractive business currently valued by the stock market at substantially below its strategic value.お知らせ • Apr 16Porvair plc Approves Final DividendPorvair plc at its AGM held on April 14, 2026, approved final dividend of 4.5 pence per ordinary share.お知らせ • Feb 11Porvair plc Recommends Final Dividend, Payable on 8 June 2026The Directors of Porvair plc recommend the payment of a final dividend of 4.5 pence per share (2024: 4.2 pence per share) to be paid on 8 June 2026 to shareholders on the register on 1 May 2026; the ex-dividend date is 30 April 2026. This makes a total dividend for the year of6.7pence per share (2024: 6.3 pence per share).お知らせ • Feb 10Porvair plc, Annual General Meeting, Apr 14, 2026Porvair plc, Annual General Meeting, Apr 14, 2026. Location: the offices of burson buchanan, rose court, 2 southwark bridge road, se1 9hs, london United Kingdomお知らせ • Feb 09Porvair plc to Report First Half, 2026 Results on Jun 29, 2026Porvair plc announced that they will report first half, 2026 results on Jun 29, 2026お知らせ • Dec 16Porvair plc Provides Earnings Guidance for the Year Ended 30 November 2025Porvair plc provided earnings guidance for the year ended 30 November 2025. For the period, the Group expects revenue growth to be around 1% (2% at constant currency), with both operating profit and margin ahead of the prior year.お知らせ • Sep 27Porvair plc Announces Board ChangesPorvair plc announced that Lisa Anson has been appointed as Non-Executive Director of the Company with effect from 1 October 2025. Lisa is currently Chief Executive Officer of Redx Pharma limited, a UK based, privately held clinical-stage biotech business; a position she held when Redx was publicly listed on AIM. In addition, she is a Supervisory Board Member for Apoplex Medical Technologies GmBH, a private German company and is an elected Board Member of the UK BioIndustry Association (BIA). She was previously a Board Member and then Chair at the Association of the British Pharmaceutical Industry (ABPI). Lisa's career spans almost 30 years in the pharmaceutical and Biotech industry including more than twenty years at AstraZeneca Plc. She has extensive global leadership and commercial experience, including several USA based roles and most recently was Country President for the UK and Ireland. On appointment, Lisa will join the Audit Committee, Remuneration Committee and Nomination Committee of Porvair. Having completed 9 years as a Non-Executive Director at Porvair, Sally Martin will retire from the Board on 4 November 2025. Following Sally's retirement, Sheena Mackay will be appointed Senior Independent Director of the Board and the Non-Executive Director responsible for employee engagement, in addition to her role as Chair of the Remuneration Committee.お知らせ • Jun 30Porvair plc Declares an Interim Dividend, Payable on 22 August 2025The Directors of Porvair plc have declared an interim dividend of 2.2 pence (2024: 2.1 pence) per share to be paid on 22 August 2025 to shareholders on the register at the close of business on 18 July 2025; the ex-dividend date is 17 July 2025.お知らせ • Jun 20Porvair plc to Report Fiscal Year 2025 Results on Feb 09, 2026Porvair plc announced that they will report fiscal year 2025 results on Feb 09, 2026お知らせ • Apr 17Porvair plc Announces Change of Remuneration Committee Chair, Effective April 15, 2025Porvair plc announced that Sheena Mackay has succeeded Sally Martin as Chair of the Remuneration Committee with effect from 15 April 2025. Sally will continue to be the Senior Independent Director and a member of the Remuneration Committee, Nomination Committee and Audit Committee. Sally retains her responsibilities as the designated Director responsible for Employee Engagement. Sheena joined the Board on 28 October 2024 as a Non-Executive Director and has been a member of the Remuneration Committee, Nomination Committee and Audit Committee since her appointment. Sheena is also a Non-Executive Director of Lords Group Trading plc, an Aim listed building material distributor, where she is Chair of the Remuneration Committee and Nomination Committee and a member of the Audit Committee.お知らせ • Feb 10Porvair plc to Report First Half, 2025 Results on Jun 30, 2025Porvair plc announced that they will report first half, 2025 results on Jun 30, 2025お知らせ • Oct 28Porvair plc Announces Appointment of Sheena Mackay as an Independent Non-Executive Director and Joins Its Audit Committee, Remuneration Committee and Nomination CommitteePorvair plc announced the appointment of Sheena Mackay as an Independent Non-Executive Director of the Company with effect from 28 October 2024. Sheena is a Non-Executive Director of Lords Group Trading plc, an Aim listed building material distributor, where she is Chair of the Remuneration Committee and Nomination Committee and a member of the Audit Committee. Sheena was a Non-Executive Director at Foxtons Group plc, the London based estate agency, from 2017 to 2023. Sheena's executive career spans more than 30 years in human capital management. Sheena was Group Human Resources Director for Smiths Group plc, a FTSE 100 global industrial technology company, between 2016 and 2022. Prior to Smiths, Sheena was Group Human Resources Director at Aggreko plc, a global supplier of temporary power and temperature control equipment, BBA Aviation plc, a multinational aviation services company, and SSL International Group plc, a multinational manufacturer and supplier of healthcare products. Prior to SSL Sheena's early career was at the General Electric Company plc, a global FTSE 100 industrial conglomerate. On appointment, Sheena will join the Audit Committee, Remuneration Committee and Nomination Committee.お知らせ • Sep 23+ 2 more updatesPorvair plc Announces Chief Executive Officer ChangesPorvair plc announce the appointment of Hooman Caman Javvi as Chief Executive Officer designate and Director of the Company. He is expected to join the Group on 6 January 2025 and assume the role of Chief Executive on the retirement of Ben Stocks following the Company's AGM on 15 April 2025. Hooman was, until recently, Group Chief Operating Officer and member of the Board of Hill & Smith plc, a FTSE 250 international provider of sustainable infrastructure products and services. Before joining Hill & Smith in 2022, Hooman spent 11 years in senior management roles at Hitachi Energy and the ABB Group. He has an Engineering and Management degree from Linkoping University in Sweden and an MBA from the Stockholm School of Economics.お知らせ • Jul 01Porvair plc Declares Interim Dividend, Payable on 21 August 2024The Directors of Porvair plc have declared an interim dividend of 2.1 pence (2023: 2.0 pence) per share to be paid on 21 August 2024 to shareholders on the register at the close of business on 19 July 2024; the ex-dividend date is 18 July 2024.お知らせ • May 25Porvair plc to Report Fiscal Year 2024 Results on Feb 10, 2025Porvair plc announced that they will report fiscal year 2024 results on Feb 10, 2025お知らせ • Apr 03Porvair plc Announces Resignation of Sarah Vawda as DirectorPorvair plc announces that Sarah Vawda resigned from the Board with immediate effect. a consequence of Sarah's resignation, AGM Resolution 10 "To elect Sarah Vawda as a Director" will be withdrawn from the resolutions to be put to the Company's AGM on 16 April 2024.お知らせ • Feb 05+ 1 more updatePorvair plc to Report First Half, 2024 Results on Jul 01, 2024Porvair plc announced that they will report first half, 2024 results on Jul 01, 2024お知らせ • Sep 07Porvair plc, Annual General Meeting, Apr 16, 2024Porvair plc, Annual General Meeting, Apr 16, 2024.お知らせ • Jul 04Porvair plc Declares an Interim Dividend, Payable on 23 August 2023Porvair plc announced the Directors have declared an interim dividend of 2.0 pence (2022: 1.9 pence) per share to be paid on 23 August 2023 to shareholders on the register at the close of business on 21 July 2023; the ex-dividend date is 20 July 2023.お知らせ • Jun 27Porvair plc Announces Appointment of Sarah Vawda as an Independent Non-Executive Director of the CompanyPorvair plc announced the appointment of Sarah Vawda as an independent Non-Executive Director of the Company with effect from 26 June 2023. Sarah is the Senior Independent Non-Executive Director and Chair of the Audit Committee of Access Intelligence plc, an AIM listedreputation management, marketing and communications,software as a service business; Non-Executive Director of Hamlet Protein A/S, a private equity backed Danish specialty protein business; and Non-Executive Director and Chair of the Remuneration and Nomination Committees ofNoveltech Private Feeds Ltd. (India),a private equity backed Indian animal nutrition business. She was formerly Non-Executive Director and Chair of the Audit and Risk Committees at Burger King UK; Trustee and Chair of the Audit Committee at The Girls Network; and Governor of the University of Bedfordshire. Sarah has previously held senior executive roles within Global multinational companies including Powergen Plc, Corus Group plc, Christian Salvesen plc, Provimi SA and Johnson Matthey plc. She qualified as a chartered accountant with PwC. On appointment, Sarah will join the Audit Committee, Remuneration Committee and Nominations Committee of Porvair plc.お知らせ • Jun 24Porvair plc to Report Fiscal Year 2023 Results on Jan 29, 2024Porvair plc announced that they will report fiscal year 2023 results on Jan 29, 2024お知らせ • May 06Porvair plc (LSE:PRV) acquired Business and Assets of HRW Inc.Porvair plc (LSE:PRV) acquired Business and Assets of HRW Inc. on March 3, 2023.Porvair plc (LSE:PRV) completed the acquisition of Business and Assets of HRW Inc. on March 3, 2023.お知らせ • May 05Porvair plc (LSE:PRV) agreed to acquire 100% stake in Ratiolab GmbH and Ratiolab Kft.Porvair plc (LSE:PRV) agreed to acquire 100% stake in Ratiolab GmbH and Ratiolab Kft. on May 4, 2023. Regulatory approval is expected to take around three months. Ratiolab has annual external revenues of around €12 million. Sally Sha, Ralf Hoffman, Jürgen Wohlfart and John Kim of EC Mergers & Acquisitions acted as exclusive financial advisor to Ratiolab.お知らせ • Jan 31Porvair plc to Report First Half, 2023 Results on Jul 03, 2023Porvair plc announced that they will report first half, 2023 results on Jul 03, 2023業績と収益の成長予測OTCPK:PVAR.F - アナリストの将来予測と過去の財務データ ( )GBP Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数11/30/20282332016N/A311/30/2027227201826411/30/2026217191424411/30/2025194181624N/A8/31/2025195181824N/A5/31/2025196172025N/A2/28/2025194171823N/A11/30/2024193161622N/A8/31/2024186161521N/A5/31/2024180151420N/A2/29/2024178161520N/A11/30/2023176161621N/A8/31/2023178161520N/A5/31/2023181161419N/A2/28/2023177151418N/A11/30/2022173151318N/A8/31/2022166131318N/A5/31/2022159121317N/A2/28/2022153121316N/A11/30/2021146121316N/A8/31/2021139111215N/A5/31/2021131101115N/A2/28/20211339913N/A11/30/20201358710N/A8/31/202014110812N/A5/31/2020146111014N/A2/29/202014611914N/A11/30/201914511913N/A8/31/201914311N/A13N/A5/31/201914111N/A13N/A2/28/201913510N/A13N/A11/30/201812910N/A13N/A8/31/201812510N/A11N/A5/31/201812110N/A9N/A2/28/20181189N/A9N/A11/30/20171169N/A9N/A8/31/20171158N/A9N/A5/31/20171138N/A9N/A2/28/20171118N/A10N/A11/30/20161098N/A11N/A8/31/20161057N/A11N/A5/31/20161027N/A11N/A2/29/2016997N/A11N/A11/30/2015967N/A11N/A8/31/2015987N/A12N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: PVAR.Fの予測収益成長率 (年間3.7% ) は 貯蓄率 ( 3.5% ) を上回っています。収益対市場: PVAR.Fの収益 ( 3.7% ) US市場 ( 18.5% ) よりも低い成長が予測されています。高成長収益: PVAR.Fの収益は増加すると予測されていますが、大幅には増加しません。収益対市場: PVAR.Fの収益 ( 6.1% ) US市場 ( 12.6% ) よりも低い成長が予測されています。高い収益成長: PVAR.Fの収益 ( 6.1% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: PVAR.Fの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YCapital-goods 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/28 11:11終値2026/05/20 00:00収益2025/11/30年間収益2025/11/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Porvair plc 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。8 アナリスト機関Andrew SimmsBerenbergJames BaylissBerenbergEleanor SpencerBerenberg5 その他のアナリストを表示
お知らせ • Dec 16Porvair plc Provides Earnings Guidance for the Year Ended 30 November 2025Porvair plc provided earnings guidance for the year ended 30 November 2025. For the period, the Group expects revenue growth to be around 1% (2% at constant currency), with both operating profit and margin ahead of the prior year.
お知らせ • Jun 12Porvair plc to Report Fiscal Year 2026 Results on Feb 08, 2027Porvair plc announced that they will report fiscal year 2026 results on Feb 08, 2027
お知らせ • May 20Richard Bernstein Calls for Sale of PorvairOn May 19, 2026, Richard Bernstein, founder and former investment manager of Crystal Amber, announced that he is reportedly calling for a sale of Porvair plc. Richard Bernstein stated that he has written to the Company’s chairman John Nicholas urging him to explore strategic alternatives for the Company. Richard Bernstein said that the Company was an attractive business currently valued by the stock market at substantially below its strategic value.
お知らせ • Apr 16Porvair plc Approves Final DividendPorvair plc at its AGM held on April 14, 2026, approved final dividend of 4.5 pence per ordinary share.
お知らせ • Feb 11Porvair plc Recommends Final Dividend, Payable on 8 June 2026The Directors of Porvair plc recommend the payment of a final dividend of 4.5 pence per share (2024: 4.2 pence per share) to be paid on 8 June 2026 to shareholders on the register on 1 May 2026; the ex-dividend date is 30 April 2026. This makes a total dividend for the year of6.7pence per share (2024: 6.3 pence per share).
お知らせ • Feb 10Porvair plc, Annual General Meeting, Apr 14, 2026Porvair plc, Annual General Meeting, Apr 14, 2026. Location: the offices of burson buchanan, rose court, 2 southwark bridge road, se1 9hs, london United Kingdom
お知らせ • Feb 09Porvair plc to Report First Half, 2026 Results on Jun 29, 2026Porvair plc announced that they will report first half, 2026 results on Jun 29, 2026
お知らせ • Dec 16Porvair plc Provides Earnings Guidance for the Year Ended 30 November 2025Porvair plc provided earnings guidance for the year ended 30 November 2025. For the period, the Group expects revenue growth to be around 1% (2% at constant currency), with both operating profit and margin ahead of the prior year.
お知らせ • Sep 27Porvair plc Announces Board ChangesPorvair plc announced that Lisa Anson has been appointed as Non-Executive Director of the Company with effect from 1 October 2025. Lisa is currently Chief Executive Officer of Redx Pharma limited, a UK based, privately held clinical-stage biotech business; a position she held when Redx was publicly listed on AIM. In addition, she is a Supervisory Board Member for Apoplex Medical Technologies GmBH, a private German company and is an elected Board Member of the UK BioIndustry Association (BIA). She was previously a Board Member and then Chair at the Association of the British Pharmaceutical Industry (ABPI). Lisa's career spans almost 30 years in the pharmaceutical and Biotech industry including more than twenty years at AstraZeneca Plc. She has extensive global leadership and commercial experience, including several USA based roles and most recently was Country President for the UK and Ireland. On appointment, Lisa will join the Audit Committee, Remuneration Committee and Nomination Committee of Porvair. Having completed 9 years as a Non-Executive Director at Porvair, Sally Martin will retire from the Board on 4 November 2025. Following Sally's retirement, Sheena Mackay will be appointed Senior Independent Director of the Board and the Non-Executive Director responsible for employee engagement, in addition to her role as Chair of the Remuneration Committee.
お知らせ • Jun 30Porvair plc Declares an Interim Dividend, Payable on 22 August 2025The Directors of Porvair plc have declared an interim dividend of 2.2 pence (2024: 2.1 pence) per share to be paid on 22 August 2025 to shareholders on the register at the close of business on 18 July 2025; the ex-dividend date is 17 July 2025.
お知らせ • Jun 20Porvair plc to Report Fiscal Year 2025 Results on Feb 09, 2026Porvair plc announced that they will report fiscal year 2025 results on Feb 09, 2026
お知らせ • Apr 17Porvair plc Announces Change of Remuneration Committee Chair, Effective April 15, 2025Porvair plc announced that Sheena Mackay has succeeded Sally Martin as Chair of the Remuneration Committee with effect from 15 April 2025. Sally will continue to be the Senior Independent Director and a member of the Remuneration Committee, Nomination Committee and Audit Committee. Sally retains her responsibilities as the designated Director responsible for Employee Engagement. Sheena joined the Board on 28 October 2024 as a Non-Executive Director and has been a member of the Remuneration Committee, Nomination Committee and Audit Committee since her appointment. Sheena is also a Non-Executive Director of Lords Group Trading plc, an Aim listed building material distributor, where she is Chair of the Remuneration Committee and Nomination Committee and a member of the Audit Committee.
お知らせ • Feb 10Porvair plc to Report First Half, 2025 Results on Jun 30, 2025Porvair plc announced that they will report first half, 2025 results on Jun 30, 2025
お知らせ • Oct 28Porvair plc Announces Appointment of Sheena Mackay as an Independent Non-Executive Director and Joins Its Audit Committee, Remuneration Committee and Nomination CommitteePorvair plc announced the appointment of Sheena Mackay as an Independent Non-Executive Director of the Company with effect from 28 October 2024. Sheena is a Non-Executive Director of Lords Group Trading plc, an Aim listed building material distributor, where she is Chair of the Remuneration Committee and Nomination Committee and a member of the Audit Committee. Sheena was a Non-Executive Director at Foxtons Group plc, the London based estate agency, from 2017 to 2023. Sheena's executive career spans more than 30 years in human capital management. Sheena was Group Human Resources Director for Smiths Group plc, a FTSE 100 global industrial technology company, between 2016 and 2022. Prior to Smiths, Sheena was Group Human Resources Director at Aggreko plc, a global supplier of temporary power and temperature control equipment, BBA Aviation plc, a multinational aviation services company, and SSL International Group plc, a multinational manufacturer and supplier of healthcare products. Prior to SSL Sheena's early career was at the General Electric Company plc, a global FTSE 100 industrial conglomerate. On appointment, Sheena will join the Audit Committee, Remuneration Committee and Nomination Committee.
お知らせ • Sep 23+ 2 more updatesPorvair plc Announces Chief Executive Officer ChangesPorvair plc announce the appointment of Hooman Caman Javvi as Chief Executive Officer designate and Director of the Company. He is expected to join the Group on 6 January 2025 and assume the role of Chief Executive on the retirement of Ben Stocks following the Company's AGM on 15 April 2025. Hooman was, until recently, Group Chief Operating Officer and member of the Board of Hill & Smith plc, a FTSE 250 international provider of sustainable infrastructure products and services. Before joining Hill & Smith in 2022, Hooman spent 11 years in senior management roles at Hitachi Energy and the ABB Group. He has an Engineering and Management degree from Linkoping University in Sweden and an MBA from the Stockholm School of Economics.
お知らせ • Jul 01Porvair plc Declares Interim Dividend, Payable on 21 August 2024The Directors of Porvair plc have declared an interim dividend of 2.1 pence (2023: 2.0 pence) per share to be paid on 21 August 2024 to shareholders on the register at the close of business on 19 July 2024; the ex-dividend date is 18 July 2024.
お知らせ • May 25Porvair plc to Report Fiscal Year 2024 Results on Feb 10, 2025Porvair plc announced that they will report fiscal year 2024 results on Feb 10, 2025
お知らせ • Apr 03Porvair plc Announces Resignation of Sarah Vawda as DirectorPorvair plc announces that Sarah Vawda resigned from the Board with immediate effect. a consequence of Sarah's resignation, AGM Resolution 10 "To elect Sarah Vawda as a Director" will be withdrawn from the resolutions to be put to the Company's AGM on 16 April 2024.
お知らせ • Feb 05+ 1 more updatePorvair plc to Report First Half, 2024 Results on Jul 01, 2024Porvair plc announced that they will report first half, 2024 results on Jul 01, 2024
お知らせ • Sep 07Porvair plc, Annual General Meeting, Apr 16, 2024Porvair plc, Annual General Meeting, Apr 16, 2024.
お知らせ • Jul 04Porvair plc Declares an Interim Dividend, Payable on 23 August 2023Porvair plc announced the Directors have declared an interim dividend of 2.0 pence (2022: 1.9 pence) per share to be paid on 23 August 2023 to shareholders on the register at the close of business on 21 July 2023; the ex-dividend date is 20 July 2023.
お知らせ • Jun 27Porvair plc Announces Appointment of Sarah Vawda as an Independent Non-Executive Director of the CompanyPorvair plc announced the appointment of Sarah Vawda as an independent Non-Executive Director of the Company with effect from 26 June 2023. Sarah is the Senior Independent Non-Executive Director and Chair of the Audit Committee of Access Intelligence plc, an AIM listedreputation management, marketing and communications,software as a service business; Non-Executive Director of Hamlet Protein A/S, a private equity backed Danish specialty protein business; and Non-Executive Director and Chair of the Remuneration and Nomination Committees ofNoveltech Private Feeds Ltd. (India),a private equity backed Indian animal nutrition business. She was formerly Non-Executive Director and Chair of the Audit and Risk Committees at Burger King UK; Trustee and Chair of the Audit Committee at The Girls Network; and Governor of the University of Bedfordshire. Sarah has previously held senior executive roles within Global multinational companies including Powergen Plc, Corus Group plc, Christian Salvesen plc, Provimi SA and Johnson Matthey plc. She qualified as a chartered accountant with PwC. On appointment, Sarah will join the Audit Committee, Remuneration Committee and Nominations Committee of Porvair plc.
お知らせ • Jun 24Porvair plc to Report Fiscal Year 2023 Results on Jan 29, 2024Porvair plc announced that they will report fiscal year 2023 results on Jan 29, 2024
お知らせ • May 06Porvair plc (LSE:PRV) acquired Business and Assets of HRW Inc.Porvair plc (LSE:PRV) acquired Business and Assets of HRW Inc. on March 3, 2023.Porvair plc (LSE:PRV) completed the acquisition of Business and Assets of HRW Inc. on March 3, 2023.
お知らせ • May 05Porvair plc (LSE:PRV) agreed to acquire 100% stake in Ratiolab GmbH and Ratiolab Kft.Porvair plc (LSE:PRV) agreed to acquire 100% stake in Ratiolab GmbH and Ratiolab Kft. on May 4, 2023. Regulatory approval is expected to take around three months. Ratiolab has annual external revenues of around €12 million. Sally Sha, Ralf Hoffman, Jürgen Wohlfart and John Kim of EC Mergers & Acquisitions acted as exclusive financial advisor to Ratiolab.
お知らせ • Jan 31Porvair plc to Report First Half, 2023 Results on Jul 03, 2023Porvair plc announced that they will report first half, 2023 results on Jul 03, 2023